Literature DB >> 6367451

Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.

N L Lasser, G Grandits, A W Caggiula, J A Cutler, R H Grimm, L H Kuller, R W Sherwin, J Stamler.   

Abstract

The Multiple Risk Factor Intervention Trial was a randomized clinical trial that studied the efficacy of multiple risk factor reduction in lowering coronary heart disease mortality in high-risk men. Nutrition counseling based on a fat-modified eating pattern resulted in a significant reduction of total cholesterol and low-density lipoprotein cholesterol. However, based on further analysis not involving comparisons of randomized groups, the reduction in total cholesterol appeared to be blunted by the effects of the antihypertensive medication utilized in the stepped-care therapy in this study. The use of diuretics was associated with an increase in triglycerides and a lesser decrease in total plasma cholesterol when compared with non-diuretic users. The use of diuretic therapy was also associated with a slight decrease in high-density lipoprotein cholesterol, when compared with changes in those not receiving diuretic therapy. The combination of diuretics plus propranolol was related to a substantial decrease in high-density lipoprotein cholesterol in both the Special Intervention and Usual Care participants. The changes in lipoproteins for men receiving diuretic therapy are probably influenced substantially by nutritional factors, especially weight change. Concomitant nutritional changes must be considered when analyzing the short- and long-term effects of therapy with diuretics or other antihypertensive drugs on lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367451     DOI: 10.1016/0002-9343(84)90957-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

Review 1.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

Review 2.  ACE inhibitors compared with thiazide diuretics as first-step antihypertensive therapy.

Authors:  I J Perry; D G Beevers
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

Review 3.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 4.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08

Review 5.  Lipid effects of antihypertensive medications.

Authors:  Roderick Deano; Matthew Sorrentino
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

Review 6.  Effects of diuretic drugs on the lipid profile.

Authors:  R Ames
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 7.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

Review 8.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

9.  A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.

Authors:  U Hauf-Zachariou; L Widmann; B Zülsdorf; M Hennig; P D Lang
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

Authors:  C Lucas; P Jenkins; J Mendels; D Due; W P Forbes; M A Sirgo
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.